Ernexa Therapeutics (ERNAW) Asset Utilization Ratio (2011 - 2024)
Ernexa Therapeutics (ERNAW) reported Asset Utilization Ratio of 0.09 for Q4 2024, up 4583.76% on a YoY basis from 0.0 in Q1 2024, and up 297.5% quarter-over-quarter from 0.02 in Q3 2024.
Ernexa Therapeutics (ERNAW) Asset Utilization Ratio (2011 - 2024) Analysis & Trends
Ernexa Therapeutics has reported Asset Utilization Ratio for 13 years, with the latest figure at 0.09 in Q4 2024.
- For the quarter ending Q4 2024, Asset Utilization Ratio rose 4583.76% year-over-year to 0.09; the trailing twelve-month figure through Dec 2024 stood at 0.09 (up 4583.76% YoY), and the FY2024 full-year result was 0.02, up 687.61% from the prior year.
- Asset Utilization Ratio for Q4 2024 stood at 0.09, up from 0.02 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 1.38 in Q1 2020, with the low at 0.0 in Q3 2023.
- Historically, Asset Utilization Ratio has averaged 0.28 across 4 years, with a median of 0.06 in 2023.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio plunged 99.51% — and 2024, when it surged 4583.76%.
- Ernexa Therapeutics' Asset Utilization Ratio stood at 1.14 in 2020, then plunged by 89.21% to 0.12 in 2022, then slumped by 98.39% to 0.0 in 2023, then soared by 4583.76% to 0.09 in 2024.
- The last three Asset Utilization Ratio figures came in at 0.09 (Q4 2024), 0.02 (Q3 2024), and 0.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ernexa Therapeutics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.06 |
| Dec 31, 2022 | 0.12 |
| Sep 30, 2022 | 0.21 |
| Dec 31, 2020 | 1.14 |
| Mar 31, 2020 | 1.38 |
| Dec 31, 2019 | 1.36 |
| Sep 30, 2019 | 1.35 |
| Jun 30, 2019 | 1.37 |
| Mar 31, 2019 | 1.43 |
| Jun 30, 2018 | 1.57 |
| Mar 31, 2018 | 1.55 |
| Dec 31, 2017 | 1.44 |
| Sep 30, 2017 | 0.65 |
| Jun 30, 2017 | 0.61 |